Firms

Santé Ventures
Austin, Texas, United States · Boston, Massachusetts, United States
Santé Ventures is an early-stage healthcare and life sciences venture capital firm founded in 2006. It invests nationally in biotechnology, medical technology and digitally enabled healthcare services, with offices in Austin, Texas, and Boston, Massachusetts. The partnership combines investment, medical, scientific and operating expertise to create and support companies addressing unmet clinical needs. Its neuroscience and deep-technology investments include ReEmerge’s investigational cognitive-network restoration platform, Sensorium Therapeutics’ CNS drug discovery and RapidPulse’s stroke-treatment technology. Santé co-led ReEmerge’s USD37 million Series A announced September 15, 2026. Its fifth venture fund closed with USD330 million in committed capital on February 2, 2026, exceeding the USD300 million target. The wider Santé platform also operates a distinct public-securities strategy, Santé Capital, using proprietary MindRank machine learning and data-science software; that strategy is not treated as an additional venture fund or private-company investment. Current named team roles distinguish venture partners, advisers and fellows from full-time investment staff. This US manager at sante.com is separate from the pre-existing company record at santehq.com.
- Founded
- 2006
- Type
- Venture capital





















